Skip to content

Amersham Corp.

United StatesFDA 510(k) applicant, unverified

Devices
94

What Amersham Corp. makes

Amersham Corp. manufactures in vitro diagnostic assays, including lateral flow and test kits for thyroid-stimulating hormone (TSH), luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactin, and anti-double-stranded DNA (anti-DSDNA). The company also produces radiopharmaceutical sources like gadolinium-153 for bone densitometry and cesium-137 microseed assemblies for medical imaging and brachytherapy applications.

The portfolio includes devices classified as Class I and Class II under FDA regulations, with submissions recorded in the 510(k) clearance pathway. These products are intended for laboratory and clinical use in the United States.

AI-generated from registry data, 1 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue94

Newest first, rows 51-94 of 94

Search and filter all 94 devices
Skip device list

Rows 51-94 of 94

Showing 51-94 of 94